Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth
Background:
Some studies have found that people can better process sugars when they take walking breaks. Studies have also found that children's attention and memory may improve after exercise. It is not known if short walking breaks have the same effects. Researchers want to study if breaking up sitting with walking for 6 days helps children s bodies use sugars and improves concentration.
Objectives:
To learn if breaking up sedentary (low-activity) time with short walking breaks over 6 days affects how children s bodies use sugar. To learn if breaking up sedentary time changes children s attention, memory, feelings, activity, or eating.
Eligibility:
Children ages 7-11 in general good health
Design:
Participants will be screened with:
- Medical history
- Physical exam
- Fasting blood tests. On 2 out of 7 total study visits, participants cannot eat or drink after 10 p.m. the night before.
- Full-body X-ray
- EKG (Electronic signals that record heart function through stickers)
- Treadmill exercise. Heart, blood pressure, and oxygen will be monitored.
- Questions about the child s health, socialization, and activity, and parent s education and economic status
- Picture vocabulary test
- Dietician meeting (Questions about eating habits)
Participants will have visits on 6 consecutive days. Over that time, they will wear 2 devices to monitor blood sugar and activity (even while at home).
Participants will have 5 after-school visits. These include:
- Health check
- Snack plus food for the next 24 hours
- Activity monitored
- 3-hour sitting tests. Participants will do non-active things. Some will have 3-minute walks every 30 minutes.
- Cognitive tests and questions about mood and anxiety are given on days #1 & 5.
Participants will fast before the last visit in the morning. They will have:
- 9 blood draws by IV catheter. Participants will drink sugar water.
- Sitting test
- Activity monitored
- Meal (food buffet)
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Background:
Sedentary behavior is defined as a set of low-intensity activities involving limited body movement (e.g.: TV viewing, prolonged sitting). Some studies have found higher levels of childhood sedentary behavior predict higher body mass index (BMI) and metabolic abnormalities. We and others have found that interrupting sitting with short, 2-3 minute bouts of moderate activity (walking) can improve glucose tolerance during a single session. Thus, interrupting sedentary behavior may be an intervention strategy to reduce health risks.
Objective:
We propose to conduct a randomized pilot study to assess whether interrupting sedentary behavior for 6 consecutive days provides sustained improvement in carbohydrate metabolism without negatively impacting executive function, attention, mood, anxiety, dietary
intake or usual physical activity.
Design & Population:
Using a randomized parallel group design, children, ages 7-11 years, will complete an assigned randomized condition of either 6 consecutive days of 3 hours of monitored sedentary activity (sitting) or 6 consecutive days of 3 hours of interrupted sitting (in which they will be prompted to walk for 3 minutes every 30 minutes).
Outcome measures:
Twenty-four-hour continuous glucose monitoring and postprandial insulin incremental area under the curve (iAUC) on post-condition oral glucose tolerance testing will be the primary measures. Secondary measures include: postprandial glucose iAUC, executive function, attention, mood, anxiety, dietary intake, and free-living physical activity.
Impact:
This project will investigate if consecutive daily interruption of sitting behaviors improves glucose tolerance, a potential negative health consequences of sedentary behavior in children. If repeatedly interrupting sitting with short bouts has sustained beneficial effects among children, interventions examining the frequency, duration, and intensity of such interruptions could be developed for use in the community setting. Thus, these results have the potential to provide insight into novel behavioral intervention targets in youth.
Tipo de estudo
Inscrição (Real)
Estágio
- Fase 2
Contactos e Locais
Locais de estudo
-
-
Maryland
-
Bethesda, Maryland, Estados Unidos, 20892
- National Institutes of Health Clinical Center
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
- INCLUSION CRITERIA:
Participants will qualify for the study if they meet the following criteria:
- Good general health.
- Age greater than or equal to 7 and less than 12 years.
- Fasting plasma glucose less than 100 mg/dL
- Body mass index (BMI) greater than or equal to the 5th percentile, as determined by the CDC age- and sex- specific growth charts.
EXCLUSION CRITERIA:
Participants will be excluded from the study for:
- Significant cardiac or pulmonary disease likely to or resulting in hypoxia or decreased perfusion.
- Evidence of impaired glucose tolerance or type 2 diabetes, including fasting plasma glucose greater than or equal to 100 mg/dL.
- Presence of other endocrinologic disorders leading to obesity (e.g.: Cushing Syndrome).
- Participants who have, or whose parent/guardians have, current substance abuse or a psychiatric disorder or other condition that, in the opinion of the investigators, would impede competence, compliance, or prevent the completion of the study.
- Participants who have, or are currently receiving, anti-psychotic drugs that would affect metabolism, cognitive outcomes, and body habitus.
- Participants receiving medical treatment other than diet for hypertension or dyslipidemia.
- Participants with precocious puberty and/or receiving androgen and estrogen therapy.
- Participants currently taking medications for ADHD, or any disorder or use of medications known to affect body composition or weight including but not limited to glucocorticoids or other steroid compounds.
- Presence of pre-existing neurocognitive disabilities, or an age-adjusted score below 85 on the Picture Vocabulary Test at the screening visit.
- Presence of food allergies, such as peanut/tree nut, dairy, soy or any other food allergy or personal dietary restrictions that would preclude participant from consuming the daily diet or the buffet.
- Presence of significant skin disease or allergy to adhesive material prohibiting placement of a continuous glucose monitor.
- Participants unable or unwilling to abstain from acetaminophen, ascorbic acid, or salicylic acid during study duration.
- Participant does not speak fluent English.
- Participant is or becomes pregnant.
- Participant has an ambulatory impairment
OPTIONAL MRS SUPPLEMENTAL ARM
INCLUSION CRITERIA
(a) Participants will qualify for the study if they qualify for the primary Break It Up! study.
EXCLUSION CRITERIA
Cannot have MRI scanning. Some of the reasons a child might not be able to have MRI include:
- Implanted cardiac pacemaker or defibrillator
- Cochlear Implants
- Ocular foreign body (e.g. metal shavings)
- Embedded shrapnel fragments
- Central nervous system aneurysm clips
- Implanted neural stimulator
- Medical infusion pumps
- Any implanted device that is incompatible with MRI.
- Is not likely to tolerate an MRI scan. Examples of medical conditions that would make it difficult to undergo MRI include severe anxiety (nervousness) or hyperactivity which make it hard for your child to lay flat for the study.
- Requires sedation for MRI studies.
- Has a condition that makes entry into the scanner difficult (e.g. weight over 550 lbs, claustrophobia, etc.).
- Has severe back-pain or motion disorders that make it hard for a child to lie on his/her back within the MRI scanner and hold still for the scan.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Sedentary
(Control intervention) Six daily 3 hour sessions with no physical activity (i.e.
subject remains sedentary in seated or recumbent position) throughout the 3 hour duration.
|
(Control 'intervention') Six daily 3 hour sessions with no physical activity (i.e.
subject remains sedentary in seated or recumbent position) throughout the 3 hour duration.
|
|
Experimental: Walking bouts
Six daily 3 hour sessions with prompted 3-minute moderate-intensity walking bouts performed on a treadmill every 30 minutes throughout the 3 hour duration.
There will be a total of 6 walking bouts (18 minutes total) each day.
Moderate-intensity walking speed and grade will be selected to achieve 80% of the heart rate achieved at the ventilatory threshold as determined during a V02max test.
|
Six daily 3 hour sessions with prompted 3-minute moderate-intensity walking bouts performed on a treadmill every 30 minutes throughout the 3 hour duration.
There will be a total of 6 walking bouts (18 minutes total) each day.
Moderate-intensity walking speed and grade will be selected to achieve 80% of the heart rate achieved at the ventilatory threshold as determined during a V02max test.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Insulin iAUC Obtained During the Oral Glucose Tolerance Test at the Final Experimental Visit.
Prazo: test day 6
|
Insulin integrated area under the curve (iAUC) as a marker of glucose metabolism on OGTT during test day #6, collected at 0, 30, 60, 90, 120, 150, and 180 minutes after oral dextrose ingestion
|
test day 6
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Glucose iAUC Obtained During the Oral Glucose Tolerance Test on Day # 6 of Intervention.
Prazo: test day 6
|
Integrated area under the curve (iAUC) for glucose values during the oral glucose tolerance test, collected at 0, 30, 60, 90, 120, 150, and 180 minutes after oral dextrose ingestion
|
test day 6
|
|
C-Peptide iAUC Obtained During the Oral Glucose Tolerance Test on Day # 6 of Intervention.
Prazo: test day 6
|
Integrated area under the curve (iAUC) for C-Peptide values during the oral glucose tolerance test, collected at 0, 30, 60, 90, 120, 150, and 180 minutes after oral dextrose ingestion
|
test day 6
|
|
Free Fatty Acid iAUC Obtained During the Oral Glucose Tolerance Test on Day # 6 of Intervention.
Prazo: test day 6
|
Integrated area under the curve (iAUC) for Free Fatty Acid values during the oral glucose tolerance test, collected at 0, 30, 60, 90, 120, 150, and 180 minutes after oral dextrose ingestion
|
test day 6
|
|
Daily Physical Activity (Step Counts/Min) During Intervention.
Prazo: test days 1-6
|
Mean 3-dimensional activity during the 3 hours of intervention from all days (step counts per minute)
|
test days 1-6
|
|
Daily Physical Activity (3-dimensional Activity Counts/Day) Outside of the Intervention.
Prazo: test days 1-6
|
Mean total daily 3-dimensional activity counts during the 21 hours without intervention on days 1-6 (activity counts/21 hours) from triaxial write accelerometers worn at home.
Note: these are not "step counts" but total 3D activity counts because motion of the wrist at times other than walking are also recorded.
There is no simple way to convert these counts to step counts.
|
test days 1-6
|
|
Energy Intake at the Final Test Meal.
Prazo: test day 6
|
Total energy intake (kcal) during buffet meal immediately after the end of intervention
|
test day 6
|
|
Percentage Fat Intake at the Final Test Meal.
Prazo: test day 6
|
Percentage Energy intake from Fat during buffet meal immediately after the end of intervention
|
test day 6
|
|
Percentage Carbohydrate Intake at the Final Test Meal.
Prazo: test day 6
|
Percentage Energy intake from Carbohydrate during buffet meal immediately after the end of intervention
|
test day 6
|
|
Percentage Protein Intake at the Final Test Meal.
Prazo: test day 6
|
Percentage Energy intake from Protein during buffet meal immediately after the end of intervention
|
test day 6
|
Colaboradores e Investigadores
Publicações e links úteis
Publicações Gerais
- Broadney MM, Belcher BR, Berrigan DA, Brychta RJ, Tigner IL Jr, Shareef F, Papachristopoulou A, Hattenbach JD, Davis EK, Brady SM, Bernstein SB, Courville AB, Drinkard BE, Smith KP, Rosing DR, Wolters PL, Chen KY, Yanovski JA. Effects of Interrupting Sedentary Behavior With Short Bouts of Moderate Physical Activity on Glucose Tolerance in Children With Overweight and Obesity: A Randomized Crossover Trial. Diabetes Care. 2018 Oct;41(10):2220-2228. doi: 10.2337/dc18-0774. Epub 2018 Aug 6.
- Belcher BR, Berrigan D, Papachristopoulou A, Brady SM, Bernstein SB, Brychta RJ, Hattenbach JD, Tigner IL Jr, Courville AB, Drinkard BE, Smith KP, Rosing DR, Wolters PL, Chen KY, Yanovski JA. Effects of Interrupting Children's Sedentary Behaviors With Activity on Metabolic Function: A Randomized Trial. J Clin Endocrinol Metab. 2015 Oct;100(10):3735-43. doi: 10.1210/jc.2015-2803. Epub 2015 Aug 27.
- Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, Shaw JE, Bertovic DA, Zimmet PZ, Salmon J, Owen N. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012 May;35(5):976-83. doi: 10.2337/dc11-1931. Epub 2012 Feb 28.
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 170130
- 17-CH-0130 (Outro identificador: NIH Clinical Center - protocol number)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Prazo de Compartilhamento de IPD
Critérios de acesso de compartilhamento IPD
Tipo de informação de suporte de compartilhamento de IPD
- Protocolo de estudo
- Termo de Consentimento Livre e Esclarecido (TCLE)
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .